Avelumab First-Line (1L) Maintenance for Advanced Urothelial Carcinoma (Uc): Long-Term Follow-Up from the Javelin Bladder 100 Trial in Subgroups Defined by 1L Chemotherapy Regimen and Analysis of Overall Survival (Os) from Start of 1L Chemotherapy.
AuthID
P-00Z-DPP
P-00Z-DPP